Related Experiment Video
Updated: Oct 23, 2025

Rapid In Vivo Fixation and Isolation of Translational Complexes from Eukaryotic Cells
Published on: December 25, 2021
Charcot-Marie-Tooth mutation in glycyl-tRNA synthetase stalls ribosomes in a pre-accommodation state and activates
Samantha Mendonsa1,2, Nicolai von Kuegelgen1,2, Lucija Bujanic1
1Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Abstract:
Toxic gain-of-function mutations in aminoacyl-tRNA synthetases cause a degeneration of peripheral motor and sensory axons, known as Charcot-Marie-Tooth (CMT) disease. While these mutations do not disrupt overall aminoacylation activity, they interfere with translation via an unknown mechanism. Here, we dissect the mechanism of function of CMT mutant glycyl-tRNA synthetase (CMT-GARS), using high-resolution ribosome profiling and reporter assays. We find that CMT-GARS mutants deplete the pool of glycyl-tRNAGly available for translation and inhibit the first stage of elongation, the accommodation of glycyl-tRNA into the ribosomal A-site, which causes ribosomes to pause at glycine codons. Moreover, ribosome pausing activates a secondary repression mechanism at the level of translation initiation, by inducing the phosphorylation of the alpha subunit of eIF2 and the integrated stress response. Thus, CMT-GARS mutant triggers translational repression via two interconnected mechanisms, affecting both elongation and initiation of translation.
Insights
Toxic mutations in glycyl-tRNA synthetase (GARS) cause Charcot-Marie-Tooth disease by disrupting translation. These GARS mutations inhibit protein elongation and trigger stress responses, leading to neurodegeneration.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- Charcot-Marie-Tooth (CMT) disease is a peripheral neuropathy linked to toxic gain-of-function mutations in aminoacyl-tRNA synthetases.
- These mutations impair translation, but the precise mechanism remains unclear despite normal aminoacylation activity.
Purpose of the Study:
- To elucidate the mechanism by which CMT mutant glycyl-tRNA synthetase (CMT-GARS) disrupts translation.
- To investigate the downstream effects of CMT-GARS on ribosome function and cellular stress responses.
Main Methods:
- High-resolution ribosome profiling to analyze translation dynamics.
- Reporter assays to assess translational control mechanisms.
Main Results:
- CMT-GARS mutants reduce the availability of glycyl-tRNAGly for translation.
- Mutants inhibit the elongation step by preventing glycyl-tRNA accommodation, causing ribosome pausing at glycine codons.
- Ribosome pausing triggers integrated stress response via eIF2 phosphorylation, repressing translation initiation.
Conclusions:
- CMT-GARS mutants induce translational repression through a dual mechanism affecting both elongation and initiation.
- This detailed understanding of translational disruption offers potential therapeutic targets for CMT disease.
Related Concept Videos
Stringent Response in E. coli
Regulation of the Unfolded Protein Response
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
The Unfolded Protein Response
Improving Translational Accuracy

